BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND CBFB, PEBP2B, 865, ENSG00000067955, Q13951 AND Diagnosis
24 results:

  • 1. Validation of an Updated Algorithm to Identify Patients With Incident Non-Small Cell lung cancer in Administrative Claims Databases.
    Patel SP; Wang R; Zhou SQ; Sheinson D; Johnson A; Lee JS
    JCO Clin Cancer Inform; 2024 Mar; 8():e2300165. PubMed ID: 38502111
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Surgical Outcomes in Non-Small Cell lung cancer with Distant Metastasis: The Prognostic Significance of Delayed Metastasis diagnosis.
    Park S; Choe J; Lee SM; Choi S; Kim MJ; Chae EJ; Seo JB
    Ann Surg Oncol; 2024 May; 31(5):3448-3458. PubMed ID: 38386197
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical characteristics and surgical outcomes of cardiac myxoma: A meta-analysis of worldwide experience.
    Oktaviono YH; Saputra PBT; Arnindita JN; Afgriyuspita LS; Kurniawan RB; Pasahari D; Milla C; Wungu CDK; Susilo H; Multazam CECZ; Alkaff FF
    Eur J Surg Oncol; 2024 Feb; 50(2):107940. PubMed ID: 38219702
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Time intervals and previous primary care consultations in the pathway to emergency cancer diagnosis.
    Bosch X; Montori-Palacin E; Calvo J; Carbonell I; Naval-Álvarez J; Moreno P; López-Soto A
    Cancer Epidemiol; 2023 Oct; 86():102445. PubMed ID: 37651939
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Evaluation of emphysema on thoracic low-dose CTs through attention-based multiple instance deep learning.
    Fuhrman J; Yip R; Zhu Y; Jirapatnakul AC; Li F; Henschke CI; Yankelevitz DF; Giger ML
    Sci Rep; 2023 Jan; 13(1):1187. PubMed ID: 36681685
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Familial risk associated with lung cancer as a second primary malignancy in first-degree relatives.
    Ji J; Sundquist J; Sundquist K; Zheng G
    BMC Cancer; 2022 Oct; 22(1):1057. PubMed ID: 36224547
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Associations Between Medicaid Insurance, Biomarker Testing, and Outcomes in Patients With Advanced NSCLC.
    Gross CP; Meyer CS; Ogale S; Kent M; Wong WB
    J Natl Compr Canc Netw; 2022 May; 20(5):479-487.e2. PubMed ID: 35545174
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Risk assessment of malignancy in solitary pulmonary nodules in lung computed tomography: a multivariable predictive model study.
    Liu HY; Zhao XR; Chi M; Cheng XS; Wang ZQ; Xu ZW; Li YL; Yang R; Wu YJ; Zhang XJ
    Chin Med J (Engl); 2021 Jun; 134(14):1687-1694. PubMed ID: 34397595
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Adequacy of small biopsy and cytology specimens for comprehensive genomic profiling of patients with non-small-cell lung cancer to determine eligibility for immune checkpoint inhibitor and targeted therapy.
    Faber E; Grosu H; Sabir S; San Lucas FA; Barkoh BA; Bassett RL; Luthra R; Stewart J; Roy-Chowdhuri S
    J Clin Pathol; 2022 Sep; 75(9):612-619. PubMed ID: 33952592
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A simple method for discrimination of carcinomatous meningitis using CEA, total protein, and total cell count in the cerebrospinal fluid of primary lung cancer patients.
    Ogawa Y; Saraya T; Noda A; Kurokawa N; Sakuma S; Aso K; Mikura S; Oda M; Ishida M; Honda K; Nakamoto K; Tamura M; Takata S; Ishii H; Takizawa H
    Medicine (Baltimore); 2021 Apr; 100(14):e25367. PubMed ID: 33832119
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Effect of compliance with GOLD treatment recommendations on COPD health care resource utilization, cost, and exacerbations among patients with COPD on maintenance therapy.
    Palli SR; Zhou S; Shaikh A; Willey VJ
    J Manag Care Spec Pharm; 2021 May; 27(5):625-637. PubMed ID: 33779246
    [No Abstract]    [Full Text] [Related]  

  • 12. Predictors of distress among patients undergoing staging investigations for suspected colorectal and lung cancer.
    Miles A; Evans REC; Taylor SA
    Psychol Health Med; 2021 Aug; 26(7):887-898. PubMed ID: 33232621
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib.
    Shang Y; Li X; Liu W; Shi X; Yuan S; Huo R; Fang G; Han X; Zhang J; Wang K; Dou Z; Zhang Y; Zang A; Zhang L
    Sci Rep; 2020 Nov; 10(1):20243. PubMed ID: 33219256
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Screening of Hub Gene Targets for lung cancer via Microarray Data.
    Su C; Liu WX; Wu LS; Dong TJ; Liu JF
    Comb Chem High Throughput Screen; 2021; 24(2):269-285. PubMed ID: 32772911
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Long-term survival trends in patients with unresectable stage III non-small cell lung cancer receiving chemotherapy and radiation therapy: a SEER cancer registry analysis.
    Hansen RN; Zhang Y; Seal B; Ryan K; Yong C; Darilay A; Ramsey SD
    BMC Cancer; 2020 Apr; 20(1):276. PubMed ID: 32248816
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Healthcare Costs and Utilization among Patients Hospitalized for Malignant Pleural Effusion.
    Shafiq M; Ma X; Taghizadeh N; Kharrazi H; Feller-Kopman DJ; Tremblay A; Yarmus LB
    Respiration; 2020; 99(3):257-263. PubMed ID: 32155630
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Risk factors analysis for one-year and long-term mortality in patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease].
    Zhang Y; Lin YX
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Dec; 42(12):895-900. PubMed ID: 31826532
    [No Abstract]    [Full Text] [Related]  

  • 18. Reduced cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in cancer Stage at diagnosis.
    Grover S; Desir F; Jing Y; Bhatia RK; Trifiletti DM; Swisher-McClure S; Kobie J; Moore RD; Rabkin CS; Silverberg MJ; Salters K; Mathews WC; Gill MJ; Thorne JE; Castilho J; Kitahata MM; Justice A; Horberg MA; Achenbach CJ; Mayor AM; Althoff KN;
    J Acquir Immune Defic Syndr; 2018 Dec; 79(4):421-429. PubMed ID: 30211722
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer.
    Korkmaz ET; Koksal D; Aksu F; Dikmen ZG; Icen D; Maden E; Onder S; Akbiyik F; Emri S
    Clin Biochem; 2018 Aug; 58():15-19. PubMed ID: 29729229
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Establishment of A Clinical Prediction Model of Solid Solitary Pulmonary Nodules].
    Yu W; Ye B; Xu L; Wang Z; Le H; Wang S; Cao H; Chai Z; Chen Z; Luo Q; Zhang Y
    Zhongguo Fei Ai Za Zhi; 2016 Oct; 19(10):705-710. PubMed ID: 27760603
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.